Author

Srishti Ramanathan

Primary ORCID profile (0009-0002-1554-4556 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Srishti RamanathaniD1 paper · Ludwig-Maximilians-Universität München

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Aishvaryaa Prabhu· 1 shared Alexander FaussneriD· 1 shared Anna Kaltenbach· 1 shared Bingni CheniD· 1 shared Christian WeberiD· 1 shared Daniel Richter· 1 shared George Shakir· 1 shared Guo Li· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Aishvaryaa Prabhu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Endothelial cannabinoid CB1 receptor deficiency reduces arterial inflammation and lipid uptake in response to atheroprone shear stress

Bingni Chen, Aishvaryaa Prabhu, Guo Li, Anna Kaltenbach, Yong Wang, George Shakir, Lucia Natarelli, Remco Megens, Yvonne Jansen, Srishti Ramanathan, Martina Geiger, Alexander Faussner, Michael Hristov, Daniel Richter, Xinyu Di, , Sabine Steffens

This paper shows that blocking endothelial CB1 receptors reduces arterial inflammation and lipid uptake under atheroprone shear stress, suggesting potential therapeutic benefits for atherosclerosis.

bioRxiv · May 15, 2024 · PreprintImmunology